SC
Shilpa Chetanbhai Thumar
About Shilpa Chetanbhai Thumar
Data last updated:
Shilpa Chetanbhai Thumar is a Director at Indo Us Bio-Tech Limited (since 2021). The company operates in Agriculture. Indo Us Bio-Tech Limited reported revenue of ₹104 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Indo Us Bio-Tech Limited L01122GJ2004PLC043550 | Director | 05 Aug 2021 | 2004 | ₹104 Cr (FY 2025) | Active |
Board colleagues of Shilpa Chetanbhai Thumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dimpy Divyangbhai Joshi | Indo Us Bio-Tech Limited | Company Secretary | |
| Hemanshi Darsh Soni | 11659183 | Indo Us Bio-Tech Limited | Director |
| Jagdishkumar Devjibhai Ajudiya | 01745951 | Indo Us Bio-Tech Limited | Managing Director |
| Malti Jagdishbhai Ajudia | 02403878 | Indo Us Bio-Tech Limited | Whole-Time Director |
| Priyanka Samarth Patel | 07941023 | Indo Us Bio-Tech Limited | Director |
| Rinku Dipenbhai Jethva | Indo Us Bio-Tech Limited | Cfo | |
| Ritaben Nileshbhai Kikani | 08367656 | Indo Us Bio-Tech Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shilpa Chetanbhai Thumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shilpa Chetanbhai Thumar
Shilpa Chetanbhai Thumar currently holds 1 directorship: Indo Us Bio-Tech Limited (Director, since 05 Aug 2021, revenue ₹104 Cr (FY 2025)).
Shilpa Chetanbhai Thumar was first appointed on 05 Aug 2021 as Director at Indo Us Bio-Tech Limited.
The current boards of Shilpa Chetanbhai Thumar's companies include Dimpy Divyangbhai Joshi (Indo Us Bio-Tech Limited), Hemanshi Darsh Soni (Indo Us Bio-Tech Limited), Jagdishkumar Devjibhai Ajudiya (Indo Us Bio-Tech Limited), Malti Jagdishbhai Ajudia (Indo Us Bio-Tech Limited), Priyanka Samarth Patel (Indo Us Bio-Tech Limited), Rinku Dipenbhai Jethva (Indo Us Bio-Tech Limited), among others.